| Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
|---|
| 04/17/1996 | EP0401271B1 Antigen against diabetes |
| 04/17/1996 | CN1120854A Rapamycin assay |
| 04/17/1996 | CN1120586A Sweet green pepper preventing cucumber mosaic virus and cultivated by means of gene engineering |
| 04/16/1996 | US5508468 Genetic engineering; particle bombardment |
| 04/16/1996 | US5508386 An immunoglobulin molecule containing a tetrapeptide epitope within the third complementarity-determining region in the n-terminus variable domain thereof |
| 04/16/1996 | US5508291 Treatment of feline vital disease; antitumor agents |
| 04/16/1996 | US5508263 A solid matrix having a protein coatings prepared from culturing two different nucleotide sequences; repairing bone defects |
| 04/16/1996 | US5508189 Regeneration of plants from cultured guard cell protoplasts |
| 04/16/1996 | US5508188 Method of growing cells in a mammal |
| 04/16/1996 | US5508186 Has vp1 minor structural protein to vp2 major structural protein ratio higher than the ratio of naturally occurring full capsid |
| 04/16/1996 | US5508184 Genetic engineering by pre-incubating in nutrient media |
| 04/11/1996 | WO1996010637A1 Human alpha4 receptor subunit of the gaba-a receptor |
| 04/11/1996 | WO1996010634A1 Inhibitor of stem cell proliferation and uses thereof |
| 04/11/1996 | WO1996010580A2 Recombinant proteins of a pakistani strain of hepatitis e and their use in diagnostic methods and vaccines |
| 04/11/1996 | WO1996010577A1 Isolated nucleic acid molecule coding for tumor rejection antigen precursor dage and uses thereof |
| 04/11/1996 | WO1996010427A2 Cellular attachment to trans-epithelial appliances |
| 04/11/1996 | WO1996010419A2 Composition comprising a recombinant virus expressing an antigen and a recombinant virus expressing an immunostimulatory molecule |
| 04/11/1996 | WO1996010414A1 Trophinin and trophinin-assisting proteins |
| 04/11/1996 | WO1996006935A3 Arabinoxylan degrading enzymes |
| 04/11/1996 | CA2201492A1 Cellular attachment to trans-epithelial appliances |
| 04/11/1996 | CA2201281A1 Human alpha 4 receptor subunit of the gaba-a receptor |
| 04/11/1996 | CA2201119A1 Trophinin and trophinin-assisting proteins |
| 04/10/1996 | EP0705903A1 In vivo mutations and polymorphisms in the 17q-linked breast and ovarian cancer susceptibility gene |
| 04/10/1996 | EP0705902A1 17q-Linked breast and ovarian cancer susceptibility gene |
| 04/10/1996 | EP0705346A1 Monoclonal antibodies against the alpha pdgf receptor and uses thereof |
| 04/10/1996 | EP0705341A1 Hybrid receptor molecules |
| 04/10/1996 | EP0705339A1 Human cell adhesion protein aamp-1 and uses thereof |
| 04/10/1996 | EP0705336A1 Test and model for polycystic ovary syndrome and male pattern baldness |
| 04/10/1996 | EP0705334A1 Tight control of gene expression in eucaryotic cells by tetracycline-responsive promoters |
| 04/10/1996 | EP0705333A1 Transgenic production of ec-sod |
| 04/10/1996 | EP0705277A1 Prostaglandin receptor ep3 and dna encoding it |
| 04/10/1996 | EP0705276A1 Prostaglandin receptor fp and dna encoding it |
| 04/10/1996 | EP0532522B1 A permanent human hepatocyte cell line and its use in a liver assist device (lad) |
| 04/10/1996 | EP0494135B1 Human "neu" related protein p100 and use of the same for detecting preneoplastic or neoplastic cells in a human |
| 04/10/1996 | EP0387286B1 Monoclonal antibody specific to a novel epitope of the lfa-1 antigen of human t lymphocytes |
| 04/10/1996 | CN1120353A Anti-microbial agents and screening method therefor |
| 04/10/1996 | CN1120352A Stable bactericidal/permeability-increasing protein products and pharmaceutical compositions containing the same |
| 04/09/1996 | US5506136 Placing immature zygotic embryo explant on culture initiation medium, transferring successively to maintenance and development media, separating somatic embryos, drying, transferring to germination medium, converting to plants |
| 04/09/1996 | US5506135 Fab fragment, having specificities against fibrin and thrombolytic substances |
| 04/09/1996 | US5506134 Hypridoma and monoclonal antibody which inhibits blood coagulation tissue factor/factor VIIa complex |
| 04/09/1996 | US5506132 Monoclonal antibodies or binding fragments thereof |
| 04/09/1996 | US5506131 Immortalized human cell lines containing exogenous cytochrome P450 genes |
| 04/09/1996 | US5506130 Contacting bottom of container surface with mixture of cells suspended in a media to permit desired cells bound to surface, separating unbound cells, removing bound cells, suspending in second media, repeating the above steps |
| 04/09/1996 | US5506119 DNA encoding variant CD44 surface proteins associated with metastatic tumors |
| 04/09/1996 | US5506107 Selecting ligand agonists and antagonists |
| 04/09/1996 | US5506102 Methods of using the A form of the progesterone receptor to screen for antagonists of steroid intracellar receptor-mediated transcription |
| 04/09/1996 | US5505908 Adsorbing, desorbing molecular sieve within enclosure, circulation with air |
| 04/04/1996 | WO1996010083A1 Novel pesticidal proteins and strains |
| 04/04/1996 | WO1996010078A1 A monoclonal antibody to human ventricular myosin light chains |
| 04/04/1996 | WO1996010077A1 Monoclonal antibody to human cardiac myoglobin |
| 04/04/1996 | WO1996009876A1 Artificial liver apparatus and method |
| 04/04/1996 | WO1996009835A1 Novel mitogen activated protein kinase, frk |
| 04/04/1996 | WO1996009810A1 Methods for enhancing melanin synthesis in melanocytes using diacylglycerols and uses thereof |
| 04/04/1996 | WO1996009755A1 Plants with delayed or inhibited ripening or senescence |
| 04/04/1996 | WO1995030763A3 Retroviral vectors having a reduced recombination rate |
| 04/04/1996 | WO1995028482A3 Dna spacer regulatory elements responsive to cytokines and methods for their use |
| 04/04/1996 | CA2201152A1 A monoclonal antibody to human ventricular myosin light chains |
| 04/04/1996 | CA2197657A1 Novel mitogen activated protein kinase, frk |
| 04/03/1996 | EP0704534A2 Recombinant DNA viral vector for transfecting animal cells |
| 04/03/1996 | EP0704458A2 Anti-human type IV collagen antibodies and use thereof |
| 04/03/1996 | EP0703990A1 Methods of identifying potentially therapeutically effective agents and cell strains for use therein |
| 04/03/1996 | EP0703988A1 Mesothelial cell gene therapy |
| 04/03/1996 | EP0703985A1 Recombinant stratum corneum chymotryptic enzyme (scce) |
| 04/03/1996 | EP0703983A1 Regulation of plant growth |
| 04/03/1996 | EP0703978A1 Medium for long-term proliferation and development of cells |
| 04/03/1996 | CN1119877A Novel pesticidal proteins and strains |
| 04/03/1996 | CN1031465C DNA clones coding for polypeptides exhibiting human graulocyte macrophage and eosinophil cellular growth factor activity |
| 04/02/1996 | US5504198 Recombinant dna molecule coding for monoclonal antibody; diagnosis, treatment and prevention of disease |
| 04/02/1996 | US5503998 Coating exogenous genetic construction including marker gene for insertion into soybean plants onto carrier particles, accelerating into plant tissue, regenerating shoots, assaying stem segments for expression, regenerating plants having gene |
| 04/02/1996 | US5503987 Immunoassay for metallic cations and small organic molecules |
| 04/02/1996 | US5503981 Isolation of fetal cells from maternal blood to enable prenatal diagnosis |
| 03/28/1996 | WO1996009602A1 Biological analysis system self-calibration apparatus |
| 03/28/1996 | WO1996009543A1 In vitro models of cns function and dysfunction |
| 03/28/1996 | WO1996009408A1 Human galactokinase gene |
| 03/28/1996 | WO1996009392A1 RIBOZYME TREATMENT OF DISEASES OR CONDITIONS RELATED TO LEVELS OF PLASMA LIPOPROTEIN (a) [Lp(a)] BY INHIBITING APOLIPOPROTEIN (a) [APO(a)] |
| 03/28/1996 | WO1996009386A2 Allelic variation of the serotonin 5ht2c receptor |
| 03/28/1996 | WO1996009385A1 Anti-sickling beta-globin protein, compositions and methods for treating sickle cell disease |
| 03/28/1996 | WO1996009381A1 Promoter for the receptor tyrosine kinase, tie |
| 03/28/1996 | WO1996009374A1 Human galactokinase gene |
| 03/28/1996 | WO1996009373A1 Fibroblasts for the treatment of muscular disorders |
| 03/28/1996 | WO1996009372A1 Artificial organ culture system |
| 03/28/1996 | WO1996009371A1 Protein mixture prepared from serum for use as component in media for in vitro culture of animal cells |
| 03/28/1996 | WO1996009074A1 Use of a non-mammalian dna virus to express an exogenous gene in a mammalian cell |
| 03/28/1996 | WO1996007749A3 Methods and compositions for inhibiting production of replication competent virus |
| 03/28/1996 | WO1996007738A3 Modified human c3 proteins |
| 03/28/1996 | WO1996006929A3 Rapid expansion method ('rem') for in vitro propagation of t lymphocytes |
| 03/28/1996 | WO1996005314A3 Protein toxins active against lepidopteran pests |
| 03/28/1996 | CA2200835A1 Use of a non-mammalian dna virus to express an exogenous gene in a mammalian cell |
| 03/28/1996 | CA2200709A1 In vitro models of cns function and dysfunction |
| 03/28/1996 | CA2199727A1 Ribozyme treatment of diseases or conditions related to levels of plasma lipoprotein (a) ¬lp(a)| by inhibiting apolipoprotein (a) ¬apo(a)| |
| 03/28/1996 | CA2199470A1 Allelic variation of the serotonin 5ht2c receptor |
| 03/28/1996 | CA2198379A1 Fibroblasts for the treatment of muscular disorders |
| 03/27/1996 | EP0702785A1 Preserved, non-infectious control cells prepared by the modulation or modification of normal cells |
| 03/27/1996 | EP0702730A1 Germline mutations in the mts gene and method for detecting predisposition to cancer at the mts gene |
| 03/27/1996 | EP0702726A1 Immunoassay reagents and methods for detecting brequinar and analogs |
| 03/27/1996 | EP0702725A1 Method for recombinant production of biologically active polypeptides |
| 03/27/1996 | EP0702724A1 Mengovirus as a vector for expression of foreign polypeptides |
| 03/27/1996 | EP0702723A1 Biocompatible implant for the expression and secretion in vivo of a therapeutical compound |
| 03/27/1996 | EP0702722A1 Plasmids suitable for gene therapy |
| 03/27/1996 | EP0702720A1 Method for defined deletions of dna |